These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10028367)

  • 1. [Cholinesterase inhibitors in Alzheimer disease: preliminary recommendations for treatment].
    Olde Rikkert MG; Jansen RW
    Ned Tijdschr Geneeskd; 1998 Nov; 142(48):2644; author reply 2645. PubMed ID: 10028367
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rivastigmine for Alzheimer disease; evaluation of preliminary results and of structured assessment of efficacy].
    Schölzel-Dorenbos CJ
    Ned Tijdschr Geneeskd; 2002 Mar; 146(10):494. PubMed ID: 11913117
    [No Abstract]   [Full Text] [Related]  

  • 3. Third drug to treat Alzheimer's approved.
    Mayo Clin Health Lett; 2000 Aug; 18(8):4. PubMed ID: 10932951
    [No Abstract]   [Full Text] [Related]  

  • 4. Rivastigmine for Alzheimer's disease.
    Drug Ther Bull; 2000 Feb; 38(2):15-6. PubMed ID: 10829350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rivastigmine (Exelon) for Alzheimer's disease.
    Med Lett Drugs Ther; 2000 Oct; 42(1089):93-4. PubMed ID: 11015159
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rivastigmine for Alzheimer disease; evaluation of preliminary results and of structured assessment of efficacy].
    Richard E; Walstra GJ; van Campen J; Vissers E; van Gool WA
    Ned Tijdschr Geneeskd; 2002 Jan; 146(1):24-7. PubMed ID: 11802333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Featured CME topic: dementia. Medication update.
    Slagle MA
    South Med J; 2001 Jul; 94(7):678-81. PubMed ID: 11531174
    [No Abstract]   [Full Text] [Related]  

  • 8. Science commentary: rational drug design for Alzheimer's disease.
    Berger A
    BMJ; 1999 Mar; 318(7184):639. PubMed ID: 10215361
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ethical aspects of anti-Alzheimer drugs: experiences of caregivers].
    Huizing AR; Berghmans RL; Widdershoven GA; Verhey FR
    Tijdschr Gerontol Geriatr; 2002 Dec; 33(6):246-51. PubMed ID: 12611287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rivastagmine-induced agitation following transient recollection of autobiographical memory.
    Caffarra P; Majer S; Godani M; Paolello P
    Neurol Sci; 2001 Jun; 22(3):279-80. PubMed ID: 11731885
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of journal advertisements on prescribers of cholinesterase inhibitors.
    Sauer J; Howard R
    Int J Geriatr Psychiatry; 2002 Oct; 17(10):976-8. PubMed ID: 12325061
    [No Abstract]   [Full Text] [Related]  

  • 12. Commentary: Another piece of the Alzheimer's jigsaw.
    Bayer T
    BMJ; 1999 Mar; 318(7184):639. PubMed ID: 10215360
    [No Abstract]   [Full Text] [Related]  

  • 13. [Alzheimer disease. Pseudo-irreversible AChE inhibition with rivastigmine].
    Med Monatsschr Pharm; 1998 Aug; 21(8):248-9. PubMed ID: 9758554
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of rivastigmine in Alzheimer's disease. Patients' view on quality of life should be assessed.
    Selai CE; Trimble MR; Rossor MN; Harvey RJ
    BMJ; 1999 Sep; 319(7210):641-2. PubMed ID: 10523095
    [No Abstract]   [Full Text] [Related]  

  • 15. Rivastigmine in the treatment of alcohol-induced persisting dementia.
    Gibson RC; Barnaby L
    West Indian Med J; 2003 Mar; 52(1):59-61. PubMed ID: 12806761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of rivastigmine in Alzheimer's disease. Guidelines do not ignore clinically relevant end points.
    Storosum JG; van Zwieten-Boot BJ; Elferink AJ
    BMJ; 1999 Sep; 319(7210):642. PubMed ID: 10523096
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cholinesterase inhibitors in Alzheimer disease; preliminary recommendations for the practice].
    Van Zwieten-Boot BJ; Lekkerkerker JF
    Ned Tijdschr Geneeskd; 1998 Nov; 142(48):2644-5; author reply 2645-6. PubMed ID: 10028368
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythematous maculopapular eruption due to rivastigmine therapy.
    Monastero R; Lopez G; Mannino M; Camarda R
    Am J Med; 2001 Nov; 111(7):583-4. PubMed ID: 11705442
    [No Abstract]   [Full Text] [Related]  

  • 19. Medications for the treatment of Alzheimer's disease.
    Lampley-Dallas VT
    J Okla State Med Assoc; 2001 Aug; 94(8):347-9. PubMed ID: 11515383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
    Gasser US; Gasser T
    MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.